INDSWIFT LABORATORIES
Back to Balance Sheet
|
INDSWIFT LABORATORIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹1,394 Cr | ₹1,133 Cr | ₹1,794 Cr | ₹1,749 Cr | ₹1,758 Cr |
What is the latest Total Liabilities ratio of INDSWIFT LABORATORIES ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹1,394 Cr |
| Mar2024 | ₹1,133 Cr |
| Mar2023 | ₹1,794 Cr |
| Mar2022 | ₹1,749 Cr |
| Mar2021 | ₹1,758 Cr |
How is Total Liabilities of INDSWIFT LABORATORIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,394 Cr | 22.98 | |
| Mar2024 | ₹1,133 Cr | -36.84 | |
| Mar2023 | ₹1,794 Cr | 2.59 | |
| Mar2022 | ₹1,749 Cr | -0.52 | |
| Mar2021 | ₹1,758 Cr | - | |
Compare Total Liabilities of peers of INDSWIFT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDSWIFT LABORATORIES | ₹1,873.5 Cr | 7.3% | 36.7% | 98.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,593.0 Cr | 2% | 6.7% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,361.0 Cr | 3.5% | 2.2% | 0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹164,290.0 Cr | 4.6% | 9.9% | 41.5% | Stock Analytics | |
| CIPLA | ₹115,655.0 Cr | -0.3% | 3.7% | -2.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,573.0 Cr | 1.1% | 5.9% | 6.6% | Stock Analytics | |
INDSWIFT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDSWIFT LABORATORIES | 7.3% |
36.7% |
98.6% |
| SENSEX | 2.2% |
5.1% |
-7% |
You may also like the below Video Courses